Holen Sie sich die Stockscreener-App
102.17
3.92%
-4.17
Handel nachbörslich:
102.23
0.06
+0.06%
Schlusskurs vom Vortag:
$106.34
Offen:
$107.71
24-Stunden-Volumen:
1.80M
Relative Volume:
1.02
Marktkapitalisierung:
$7.80B
Einnahmen:
$8.10B
Nettoeinkommen (Verlust:
$599.48M
KGV:
13.81
EPS:
7.3969
Netto-Cashflow:
$971.25M
1W Leistung:
-14.63%
1M Leistung:
+0.88%
6M Leistung:
-42.64%
1J Leistung:
-29.98%
1-Tages-Spanne:
$99.93
$107.71
1-Wochen-Bereich:
$99.93
$119.45
52-Wochen-Spanne:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
102.17 | 7.80B | 8.10B | 599.48M | 971.25M | 7.3969 |
TMO
Thermo Fisher Scientific Inc
|
469.71 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.25 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
565.93 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.55 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
309.87 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-18 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-17 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Herabstufung | Truist | Buy → Hold |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
ICON announces CEO transition - MSN
Icon PLC (MEX:ICLRN) Stock Price & 30 Year Financial Data - GuruFocus
Icon PLC (MEX:ICLRN) Stock Earnings Transcripts - GuruFocus
Earnings Preview: Icon PLC to Report Financial Results Post-market on April 30 - Moomoo
Is Icon PLC (ICLR) a Bargain After 4.0% Drop? GF Value Says Unde - GuruFocus
Buffalo International Fund's Icon PLC(ICLR) Holding History - GuruFocus
Clinical Trial Data Visualization Research Report 2026: $1.82 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
A Look at Icon PLC (ICLR) After 7.9% Decline -- GF Value $243.03 vs Price $106.34 - GuruFocus
ICON (ICLR) slides as investors stay cautious ahead of delayed results tied to accounting review - Quiver Quantitative
Icon (NASDAQ:ICLR) Shares Gap DownShould You Sell? - MarketBeat
Pre-Market Movement | Icon PLC Falls Nearly 7% in Pre-Market Trading - 富途牛牛
Is ICON plc (ICLR) stock cheap relative to earnings growth | ICON plc Posts 1.2% EPS Miss On Solid Quarterly Revenue - Xã Thanh Hà
M&T Bank Corp Has $31.50 Million Holdings in Icon Plc $ICLR - MarketBeat
16,248 Shares in Icon Plc $ICLR Purchased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
ICLR (ICON plc Ordinary Shares) falls 0.79% following Q3 2025 slight EPS miss and modest 2% year over year revenue growth.Operating Margin - Cổng thông tin điện tử tỉnh Tây Ninh
Icon (ICLR) to Release Quarterly Earnings on Wednesday - MarketBeat
Icon Plc (NASDAQ:ICLR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
ICLR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ICON plc options imply 11.5% move in share price post-earnings - TipRanks
Hudson Edge Investment Partners Inc. Has $47.46 Million Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Analysis: Potential Upside with Strategic Global Reach Captivates Investors - DirectorsTalk Interviews
Icon PLC (MEX:ICLRN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
MEX:ICLRN EV-to-EBIT: 13.38 — 37% Below Median - GuruFocus
Icon Plc $ICLR Shares Sold by Ninety One UK Ltd - MarketBeat
Ninety One North America Inc. Purchases 12,552 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Fisher Funds Management LTD - MarketBeat
ICON plc options imply 9.7% move in share price post-earnings - TipRanks
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $120 - 富途牛牛
ICON plc stock (IE0005711209): Why its clinical trial dominance matters more now for U.S. investors? - AD HOC NEWS
ICON Launches New Functional Service Provision (FSP) Strategy - AOL.com
USS Investment Management Ltd's Icon PLC(ICLR) Holding History - GuruFocus
Is It Too Late to Buy Icon PLC (ICLR) After 3.0% Rally? GF Value Says Undervalued - GuruFocus
Icon Plc (NASDAQ:ICLR) Short Interest Update - MarketBeat
Timber Creek Capital Management LLC Makes New $5.65 Million Investment in Icon Plc $ICLR - MarketBeat
Is ICON (NasdaqGS:ICLR) Offering An Opportunity After Recent Share Price Volatility? - Sahm
ICON plc stock (IE0005711209): Is clinical trial demand strong enough to drive U.S. investor upside? - AD HOC NEWS
Massachusetts Financial Services Co. MA Has $429.50 Million Holdings in Icon Plc $ICLR - MarketBeat
ALTRINSIC GLOBAL ADVISORS LLC's Icon PLC(ICLR) Holding History - GuruFocus
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neogen (NEOG) - The Globe and Mail
What does insider activity suggest for ICON plc (ICLR) Stock | Price at $104.66, Down 1.92%Trending Social Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $180 - 富途牛牛
Trinity Street Asset Management LLP Increases Stock Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Forecasts - Yahoo! Finance Canada
ICON Public Limited Company (ICLR) stock price, news, quote and history - Yahoo Finance UK
Icon Plc $ICLR Shares Acquired by Aberdeen Group plc - MarketBeat
Downgrading Icon's Moat Rating to None; Yet Shares Appear Undervalued Amid Significant Pullback - Morningstar
Icon: Downgrading Moat Rating to None; Yet Shares Appear Undervalued Amid Significant Pullback - Morningstar
How ICON’s AI-Focused Partnership with Advarra Could Reshape ICLR’s Clinical Trial Efficiency Narrative - simplywall.st
Healthcare Rpo Market Is Going to Boom | • ICON plc • Syneos Health • Labcorp - openPR.com
ICLR Technical Analysis & Stock Price Forecast - Intellectia AI
Icon (NASDAQ:ICLR) Shares Unloaded Rep. Kevin Hern - MarketBeat
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):